Notice of Effectiveness · EFFECT
Evaxion A/S
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-11-13
- Effective time (as filed)
- 16:00:00
- Form
- F-1
Registrant 1
- Registrant
- Evaxion A/S
- Registrant CIK
- 0001828253
- File number
- 333-291685
Company context
Evaxion A/S is a pioneering clinical-stage TechBio company based upon the Artificial Intelligence (AI) platform: AI-Immunology™. The AI-Immunology™ platform consists of five proprietary and scalable AI prediction models harnessing the power of data, machine learning and artificial intelligence to decode the human immune system. This enables the development of novel vaccines for the treatment of cancer as well as bacterial and viral infections.